Table	Area	Information in the Table
1	ACS	ACS approved varieties for 2003
2 & 3	ACS	Three-year performance of approved varieties - all districts
4-Mhd – 4-Dtn	ACS	Three-year performance of approved varieties -individual factory districts
5	ACS	Performance of approved varieties with commercial seed – all districts
6-Mhd – 6-Dtn	ACS	Performance of approved varieties with commercial seed – individual factory districts
7	ACS	Two-year performance of all approved varieties (including specialty) – all districts
8	ACS	Performance of specialty varieties  under Aphanomyces and Rhizomania conditions
9	ACS	2002 ACS Commercial trial – all characters
10	ACS	2002 ACS Semi-commercial trial – all characters
11 & 12	ACS & MD	Biotech variety performance
13	ACS & MD	Seed companies in 2002 official trials
14	MD	Minn-Dak approved varieties for 2003
15 & 16	MD	Three-year performance of approved varieties – Minn-Dak
17	MD	2002 Minn-Dak Commercial trial – all characters
18	MD	2002 Minn-Dak Semi-commercial trial – all characters
19	ACS & MD	Aphanomyces disease nursery ratings
20	ACS & MD	Cercospora disease nursery ratings
21	ACS & MD	Official trial locations, planting and harvest dates
22	ACS & MD	Grower fall soil test results for 2002 official trial locations
23	ACS	Aphanomyces incidence at ACS trial sites
24	ACS & MD	Herbicides applied to 2002 official trials
25	ACS & MD	Fungicides applied to 2002 official trials
26	ACS	Approval calculations for ACS unlimited market
27	ACS	Approval calculations for ACS test market
28	ACS	Approval calculations for ACS Aphanomyces specialty
29	ACS	Approval calculations for ACS Rhizomania specialty
30	ACS	Approval calculations for ACS Rhizoctonia specialty
31	ACS	Approval status for ACS biotech
32	MD	Approval calculations for Minn-Dak